$345 Million is the total value of Cormorant Asset Management, LP's 37 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2013 |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
QUOTIENT LTD | 30 | Q3 2021 | 4.3% |
ASCENDIS PHARMA A/S | 30 | Q4 2022 | 4.8% |
MINERVA NEUROSCIENCES INC | 29 | Q3 2021 | 4.4% |
ACCELERON PHARMA INC | 28 | Q2 2021 | 3.4% |
OMEROS CORP | 27 | Q3 2021 | 6.5% |
APELLIS PHARMACEUTICALS INC | 26 | Q1 2024 | 8.6% |
MIRATI THERAPEUTICS INC | 25 | Q4 2022 | 7.6% |
BLUEPRINT MEDICINES CORP | 25 | Q3 2021 | 3.6% |
ROCKET PHARMACEUTICALS, INC | 25 | Q1 2024 | 2.4% |
NEUROCRINE BIOSCIENCES INC | 24 | Q1 2020 | 4.6% |
View Cormorant Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Rapport Therapeutics, Inc. | June 20, 2024 | 1,283,673 | - |
CytomX Therapeutics, Inc. | May 13, 2024 | 5,750,000 | - |
TScan Therapeutics, Inc. | April 29, 2024 | 2,500,000 | - |
Immuneering Corp | April 15, 2024 | 561,128 | - |
Ventyx Biosciences, Inc. | March 21, 2024 | 3,670,000 | - |
Corbus Pharmaceuticals Holdings, Inc. | March 18, 2024 | 2,025,000 | - |
89bio, Inc.Sold out | February 14, 2024 | 0 | - |
Aerovate Therapeutics, Inc.Sold out | February 14, 2024 | 0 | - |
ALPINE IMMUNE SCIENCES, INC. | February 14, 2024 | 2,550,000 | - |
Ambrx Biopharma, Inc. | February 14, 2024 | 8,725,040 | - |
View Cormorant Asset Management, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-09-25 |
4 | 2024-09-24 |
N-PX | 2024-08-30 |
13F-HR | 2024-08-14 |
SC 13G | 2024-06-20 |
4 | 2024-06-13 |
13F-HR | 2024-05-15 |
SC 13G | 2024-05-13 |
4 | 2024-05-08 |
SC 13G | 2024-04-29 |
View Cormorant Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.